Therapeutic targets in systemic sclerosis
The precise aetiology of systemic sclerosis (SSc) remains elusive, but significant advances over the past few years have improved our understanding of the underlying pathogenic processes and identified key pathways and mediators that are potential therapeutic targets. The situation is complicated by...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
BioMed Central|1
2007
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2072882/ |